Seritage Growth Properties
SRG NYSE Real Estate Financials FY2016βFY2025
What Seritage Growth Properties does
No business description yet.
- Legal name
- Seritage Growth Properties
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0001193125-26-134736
0001628063
Revenue and margins
Seritage Growth Properties had $18.2M of revenue in fiscal 2025, up 3.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Seritage Growth Properties returned β to shareholders in fiscal 2025. The diluted share count rose 0.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Seritage Growth Properties can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $107M | $133M | $134M | $85.2M | $48.1M |
| Total assets | $2.4B | $1.8B | $974M | $678M | $394M |
| Total liabilities | $1.6B | $1.1B | $411M | $272M | $61.0M |
| Shareholders' equity | $688M | $720M | $562M | $404M | $331M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 2 / 7 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β5.5% | β4.9% | β4.5% | β0.1% | β2.1% | 4.3% | 2.1% | β7.2% | β12.1% | β6.2% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $249M | $241M | $215M | $169M | $116M | $117M | $107M | $20.8M | $17.6M | $18.2M |
| Operating income | β$30.4M | β$115M | β | β | β | β | β | β | β | β |
| Interest expense | $63.6M | $70.1M | $90.0M | $94.5M | $91.3M | $108M | $86.7M | $44.6M | $25.0M | $20.3M |
| Pretax income | β$90.5M | β$121M | β$115M | β$90.4M | β$153M | β$38.8M | β$120M | β$155M | β$152M | β$68.2M |
| Income tax | $0.5M | $0.3M | $0.3M | $0.2M | $0.3M | $0.2M | $0.5M | $0.0M | $1.6M | $0.0M |
| Net income | β$51.6M | β$73.8M | β$73.5M | β$59.4M | β$105M | β$28.1M | β$73.9M | β$155M | β$154M | β$68.2M |
| Net income to common | β$51.6M | β$74.0M | β$78.4M | β$64.3M | β$110M | β$33.0M | β$78.8M | β$160M | β$158M | β$73.1M |
| Diluted EPS | β$1.64 | β$2.19 | β$2.20 | β$1.77 | β$2.87 | β$0.78 | β$1.59 | β$2.85 | β$2.82 | β$1.30 |
| Diluted shares | 0.03B | 0.03B | 0.04B | 0.04B | 0.04B | 0.04B | 0.05B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $97.2M | $59.6M | $54.9M | β$57.7M | β$47.3M | β$136M | β$118M | β$53.1M | β$53.5M | β$34.9M |
| Depreciation and amortization | $177M | $262M | $227M | $105M | $96.0M | $51.2M | $41.1M | $14.5M | $13.1M | $6.3M |
| Stock-based compensation | $1.1M | $7.0M | $7.5M | $6.8M | β$3.0M | $1.9M | $2.8M | $2.7M | $1.5M | $0.2M |
| Dividends paid | $39.4M | $34.2M | $35.7M | $18.0M | β | β | β | β | β | β |
| Dividends and buybacks | $39.4M | $34.2M | $35.7M | $18.0M | β | β | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $52.0M | $242M | $533M | $139M | $144M | $107M | $133M | $134M | $85.2M | $48.1M |
| Total debt | $1.2B | $1.2B | β | β | β | β | β | β | β | β |
| Finance lease liabilities | β | β | β | β | $20.1M | $20.6M | β | β | β | β |
| Intangible assets | $464M | $310M | $124M | $68.2M | $18.6M | $14.8M | $1.8M | $0.9M | $1.0M | $0.2M |
| Total assets | $2.7B | $2.8B | $2.9B | $2.8B | $2.6B | $2.4B | $1.8B | $974M | $678M | $394M |
| Total liabilities | $1.3B | $1.5B | $1.7B | $1.7B | $1.8B | $1.6B | $1.1B | $411M | $272M | $61.0M |
| Shareholders' equity | $805M | $887M | $781M | $731M | $649M | $688M | $720M | $562M | $404M | $331M |
| Margins | ||||||||||
| Operating margin | β12.2% | β47.5% | β | β | β | β | β | β | β | β |
| EBITDA margin | 59.0% | 61.2% | β | β | β | β | β | β | β | β |
| Net margin | β20.7% | β30.6% | β34.2% | β35.2% | β90.2% | β24.1% | β69.1% | β745.5% | β871.3% | β374.7% |
| Returns | ||||||||||
| Return on capital | β1.3% | β4.9% | β | β | β | β | β | β | β | β |
| Return on equity | β6.4% | β8.7% | β8.8% | β7.9% | β15.2% | β4.2% | β10.5% | β24.2% | β31.8% | β18.5% |
| Return on assets | β1.9% | β2.7% | β2.6% | β2.1% | β3.9% | β1.1% | β3.5% | β11.0% | β18.6% | β12.7% |
| Return on tangible equity | β15.2% | β12.8% | β11.9% | β9.7% | β17.4% | β4.9% | β11.0% | β28.5% | β39.3% | β22.1% |
| Growth | ||||||||||
| Revenue growth | β | β3.1% | β10.9% | β21.5% | β30.9% | 0.2% | β8.3% | β80.6% | β15.2% | 3.3% |
| Share count change | β | 7.6% | 5.2% | 2.4% | 5.2% | 10.7% | 17.3% | 12.9% | 0.2% | 0.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 7.6x | 6.5x | β | β | β | β | β | β | β | β |
| Debt / equity | 1.5x | 1.4x | β | β | β | β | β | β | β | β |
| Interest coverage | β0.5x | β1.6x | β | β | β | β | β | β | β | β |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.4% | 2.9% | 3.5% | 4.1% | β2.6% | 1.6% | 2.6% | 13.2% | 8.4% | 1.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 2.0 | β | β | β | β | β | β | β | β |
| Accruals ratio | β5.5% | β4.9% | β4.5% | β0.1% | β2.1% | 4.3% | 2.1% | β7.2% | β12.1% | β6.2% |
Source: SEC EDGAR XBRL filings (CIK 0001628063). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.